Early detection and intervention with schizophrenia: Rationale

Schizophrenia Bulletin

Volumn 22, Issue 2, 1996, Pages 201-222

  McGlashan, Thomas H ^a,b   Johannessen, Jan Olav ^c  

^a Yale New Haven Psychiatric Hospital   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029967169     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.2.201     Document Type: Article

References (133)

1. American Psychiatric Association. DSM-III: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: The Association, 1980.
2. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: The Association, 1987.
3. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association, 1994.
4. Ammons, R.B., and Ammons, C.H. The Quick Test (QT): Provisional Manual. Psychological Reports, 11:111-162, 1962.
5. Andreasen, N.C. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: The University of Iowa, 1984.
6. Andreasen, N.C. "Is the Neuropsychological Deficit in Schizophrenia Progressive? New Research." Presented at the Annual Meeting of the American Psychiatric Association, Philadelphia, PA, May 1994.
7. Angrist, B., and Schulz, S.C., eds. Introduction to the Neuroleptic-Non-responsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press, 1990.
8. Asarnow, R.F.; Granholm, E.; and Sherman, T. Span of apprehension in schizophrenia. In: Steinhauer, S.; Gruzelier, J.H.; and Zubin, J., eds. Handbook of Schizophrenia. Neuropsychology, Psychophysiology, and Information Processing. Vol. 5. Amsterdam, The Netherlands: Elsevier Science Publishers, 1991. pp. 335-370.
9. Astrup, C., and Noreik, K. Functional Psychoses: Diagnostic and Prognostic Models. Springfield, IL: Charles C Thomas, 1966.
10. Bakan, P., and Peterson, K. Pregnancy and birth complications: A risk factor for schizotypy. Journal of Personality Disorders, 8(4):299-306, 1994.
11. Barr, CE.; Mednick, S.A.; and Munk-Jorgenson, J.P. Exposure to influenza epidemics during gestation and adult schizophrenia: A 40-year study. Archives of General Psychiatry, 47:869-874, 1990.
12. Bell, R.Q. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55:370-381, 1992.
13. Bellack, A.S. "Problem Solving Deficits in Schizophrenia." Presented at the Annual Meeting of the American Psychiatric Association, Miami, FL, May 1995.
14. Benedict, R.H.B.; Harris, A.E.; Markow, T.; McCormick, J.A.; Nuechterlein, K.H.; and Asarnow, R.F. Effects of attention training on information processing in schizophrenia. Schizophrenia Bulletin, 20(3):537-545, 1994.
15. Bilder, R.M.; Lipschutz-Broch, L.; Reiter, G.; Geisler, S.H.; Mayerhoff, D.I.; and Lieberman, J.A. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophrenia Bulletin, 18(3):437-448, 1992.
16. Birchwood, M.; Cochrane, R.; MacMillan, J.F.; Copestake, S.; Kucharaska, J.; and Cariss, M. The influence of ethnicity and family structure on relapse in first-episode schizophrenia: A comparison of Asian, Afro-Caribbean, and White patients. British Journal of Psychiatry, 161:783-790, 1992.
17. Bleuler, E. Dementia Praecox, or the Group of Schizophrenias. [1911] Translated by J. Zinkin. New York, NY: International Universities Press, 1950.
18. Bleuler, M. Schizophrenic deterioration. British Journal of Psychiatry, 143:78-79, 1983.
19. Calev, A.; Fennig, S.; Jandorf, L.; and Bromet, E. "Factors Associated with Neuropsychological Performance in First-Admission Psychotic Patients." Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.
20. Cannon, T.D.; Mednick, S.A.; Parnas, J.; Schulsinger, F.; Praestholm, J.; and Vestergaard, A.A. Developmental brain abnormalities in the offspring of schizophrenic mothers: I. Contributions of genetic and perinatal factors. Archives of General Psychiatry, 50:551-564, 1993.
21. Carone, B.J.; Harrow, M.; and Westermeyer, J.F. Posthospital course and outcome in schizophrenia. Archives of General Psychiatry, 48:247-253, 1991.
22. Carpenter, W.T., Jr., and Buchanan, R.W. Schizophrenia. New England Journal of Medicine, 330(10):681-690, 1994.
23. Carpenter, W.T., Jr.; Heinrichs, D.W.; and Wagman, A.M.I. Deficit and nondeficit forms of schizophrenia: The concept. American Journal of Psychiatry, 145:578-583, 1988.
24. Ciompi, L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 6(4):606-618, 1980.
25. Clementz, B.A.; Grove, W.M.; Iacono, W.G.; and Sweeney, J.A. Smooth-pursuit eye movement dysfunction and liability for schizophrenia: Implications for genetic modeling. Journal of Abnormal Psychology, 101(1):117-129, 1992.
26. Cohen, B.M.; Renshaw, P.F.; and Yurgelun-Todd, D. Imaging the mind: Magnetic resonance spectroscopy and functional brain imaging. American Journal of Psychiatry, 152(5):655-658, 1995.
27. Coryell, W., and Tsuang, M.T. DSM-III schizophreniform disorder. Archives of General Psychiatry, 39:66-69, 1982.
28. Crow, T.J.; MacMillan, J.F.; Johnson, A.L.; and Johnstone, E.C. A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148:120-127, 1986.
29. Dalen, P. Schizophrenia, season of birth, and maternal age. British Journal of Psychiatry, 153:727-733, 1988.
30. Davidson, M.; Harvey, P.D.; Powchik, P.; Parrella, M.; White, L.; Knobler, H.Y.; Losonczy, M.F.; Keefe, R.S.E.; Katz, S.; and Frecska, E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. American Journal of Psychiatry, 152:197-207, 1995.
31. Eaton, W.W.; Mortensen, P.B.; Herrman, H.; Freeman, H.; Bilker, W.; Burgess, P.; and Wooff, K. Long-term course of hospitalization for schizophrenia: I. Risk for rehospitalization. Schizophrenia Bulletin, 18(2):217-228, 1992a.
32. Eaton, W.W.; Mortensen, P.B.; Herrman, H.; Freeman, H.; Bilker, W.; Burgess, P.; and Wooff, K. Long-term course of hospitalization for schizophrenia: II. Change with passage of time. Schizophrenia Bulletin, 18(2):229-242, 1992b.
33. Edwards, J.; Francey, S.M.; McGorry, P.D.; and Jackson, H.J. Early psychosis prevention and intervention: Evolution of a comprehensive community-based specialized service. Behavior Change, 11(4):223-233, 1994.
34. Engelhardt, D.M.; Rosen, B.; Feldman, J.; Engelhardt, J.Z.; and Cohen, P. A 15-year followup of 646 schizophrenic outpatients. Schizophrenia Bulletin, 8(3):493-503, 1982.
35. Erlenmeyer-Kimling, L. High-risk research in schizophrenia: A summary of what has been learned. Journal of Psychiatric Research, 21(4):401-411, 1987.
36. Falloon, I.R.H. Early intervention for first episodes of schizophrenia: A preliminary exploration. Psychiatry, 55:4-15, 1992.
37. Falloon, I.R.H.; Boyd, J.L.; McGill, C.W.; Williamson, M.; Razani, J.; Moss, H.B.; Gilderman, A.M.; and Simpson, G.M. Family management in the prevention of morbidity of schizophrenia. Archives of General Psychiatry, 42:887-896, 1985.
38. Falloon, I.R.H.; Kydd, R.R.; Coverdale, J.H.; and Laidlaw, T.M. Early detection and intervention for initial episodes of schizophrenia. Schizophrenia Bulletin, 22(2):271-282, 1996.
39. Feinberg, I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17(4):319-334, 1982.
40. Fenton, W.S., and McGlashan, T.H. Sustained remission in drug-free schizophrenic patients. American Journal of Psychiatry, 144(10):1306-1309, 1987.
41. Fenton, W.S., and McGlashan, T.H. Natural history of schizophrenia subtypes: I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry, 48:969-977, 1991a.
42. Fenton, W.S., and McGlashan, T.H. Natural history of schizophrenia subtypes: II. Positive and negative symptoms and long-term course. Archives of General Psychiatry, 48:978-986, 1991b.
43. Fenton, W.S., and McGlashan, T.H. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. American Journal of Psychiatry, 151(3):351-356, 1994.
44. Folstein, M.F.; Folstein, S.E.; and McHugh, P.R. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12:189-198, 1975.
45. Ford, J.M.; Isaacks, B.C.; Lim, K.O.; and Pfefferbaum, L.A. "P300 Amplitude in Schizophrenia is Inversely Related to Duration of Illness.0" Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.
46. Goldberg, T.E.; Hyde, T.M.; Kleinman, J.E.; and Weinberger, D.R. Course of schizophrenia: Neuropsychological evidence for a static encephalopathy. Schizophrenia Bulletin, 19(4):797-804, 1993.
47. Goldberg, T.E.; Hyde, T.M.; Nawroz, S.; Kleinman, J.E.; and Weinberger, D.R. A cross-sectional study of the course of cognitive impairment in schizophrenia. [Abstract] Biological Psychiatry, 31(Suppl. 5):192-193, 1992.
48. Goldstein, G.; Zubin, J.; and Pogue-Geile, M.F. Hospitalization and the cognitive deficits of schizophrenia: The influences of age and education. Journal of Nervous and Mental Disease, 179:202-206, 1991.
49. Green, M.F. Cognitive remediation in schizophrenia: Is it time yet? American Journal of Psychiatry, 150:178-187, 1993.
50. Grinker, R.R. Changing styles in psychoses and borderline states. American Journal of Psychiatry, 130:151-152, 1973.
51. Grove, W.M.; Lebow, B.S.; Clementz, B.A.; Cerri, A.; Medus, C.; and Iacono, W.G. Familial prevalence and coaggregation of schizotypal indicators: A multitrait study. Journal of Abnormal Psychology, 100:115-121, 1991.
52. Haas, G.L.; Keshavan, M.S.; and Sweeney, J.A. "Delay to First Medication in Schizophrenia: Evidence for a Possible Negative Impact of Exposure to Psychosis." [Abstract] Presented at the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1994.
53. Hans, S., and Marcus, J. A process model for the development of schizophrenia. Psychiatry, 50:361-370, 1987.
54. Harrow, M.; Carone, B.J.; and Westermeyer, J.F. The course of psychosis in early phases of schizophrenia. American Journal of Psychiatry, 142:702-707, 1985.
55. Harrow, M., and Marengo, J.T. Schizophrenic thought disorder at followup: Its persistence and prognostic significance. Schizophrenia Bulletin, 12(3):373-393, 1986.
56. Heaton, R.; Paulsen, J.S.; McAdams, L.A.; Kuck, J.; Zisook, S.; Braff, D.; Harris, M.J.; and Jeste, D.V. Neuropsychological deficits in schizophrenics: Relationship to age, chronicity and dementia. Archives of General Psychiatry, 51:469-476, 1994.
57. Helgason, L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: What could have been prevented? Acta Psychiatrica Scandinavica, 81:231-235, 1990.
58. Hoff, A.L.; Riordan, H.; O'Donnell, D.W.; Morris, L.; and DeLisi, L.E. Neuropsychological functioning of first-episode schizophreniform patients. American Journal of Psychiatry, 149(7):898-903, 1992.
59. Hoffman, R.E., and McGlashan, T.H. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophrenia Bulletin, 19(1):119-140, 1993.
60. Hoffman, R.E.; Rapaport, J.; Ameli, R.; McGlashan, T.H.; Harcherik, D.; and Servan-Schreiber, D. A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients. Journal of Cognitive Neuroscience, 7(4):479-496, 1995.
61. Hogarty, G.E., and Gross, M. Preadmission symptom differences between first-admitted schizophrenics in the predrug and postdrug era. Comprehensive Psychiatry, 7:134-140, 1966.
62. Hollister, J.M.; Laing, P.; and Mednick, S.A. Rhesus incompatability as a risk-factor for schizophrenia in male adults. Archives of General Psychiatry, 53:19-24, 1996.
63. Huber, G.; Gross, G.; and Schuttler, R. Schizophrenie. Monographien aus dem Gesamtgebiete der Psychiatrie. Berlin, Germany: Springer Verlag, 1979.
64. Hüttenlocher, P.R. Synaptic density in the human frontal cortex: Developmental changes and effects of aging. Brain Research, 163:195-205, 1979.
65. Inoue, K.; Nakajima; T.; and Kato, N. A longitudinal study of schizophrenia in adolescence: I. The one to three year outcome. Japanese Journal of Psychiatry and Neurology, 40:143-151, 1986.
66. Israel, R., and Johnson, N.A. Discharge and readmission rates in 4,254 consecutive first admissions of schizophrenia. American Journal of Psychiatry, 112:903-909, 1956.
67. Johnstone, E.C.; Crow, T.J.; Johnson, A.L.; and MacMillan, J.F. The Northwick Park Study of firstepisode schizophrenia: I. Presentation of the illness and problems relating to admission. British Journal of Psychiatry, 148:115-120, 1986.
68. Kay, S.R. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. New York, NY: Brunner/Mazel, 1991.
69. Kelley, M.E.; Gilbertson, M.; Mouton, A.; and van Kammen, D.P. Deterioration in premorbid functioning in schizophrenia: A developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry, 149(11):1543-1548, 1992.
70. Kendler, K.S.; Gruenberg, A.M.; and Tsuang, M.T. Subtype stability in schizophrenia. American Journal of Psychiatry, 142:827-832, 1985.
71. Keshavan, M.S.; Pertegrew, J.W.; Kaplan, D.; and Bozik, E. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Archives of General Psychiatry, 48:1112-1113, 1991.
72. King, K.; Fraser, W.I.; Thomas, P.; and Kendell, R.E. Re-examination of the language of psychotic subjects. British Journal of Psychiatry, 156:211-215, 1990.
73. Kraepelin, E. Dementia Praecox and Paraphrenia. [1919] Translated by R.M. Barclay. New York, NY: Robert E. Krieger Publishing Company, 1971.
74. Kremen, W.S.; Seidman, L.J.; Pepple, J.R.; Lyons, M.J.; Tsuang, M.T.; and Faraone, S.V. Neuropsychological risk indicators for schizophrenia: A review of family studies. Schizophrenia Bulletin, 20(1):103-119, 1994.
75. Leboyer, M.; Jay, M.; D'Amato, T.; Campion, D.; Guilloud-Bataille, M.; Hillaire, D.; Drouet, A.; Lepe, J.P.; Boise, E.; and Feingold, J. Subtyping familial schizophrenia: Reliability, concordance and stability. Psychiatry Research, 34:77-88, 1990.
76. Lehman, A.F.; Carpenter, W.T., Jr.; Goldman, H.H.; and Steinwachs, D.M. Treatment outcomes in schizophrenia: Implications for practice, policy, and research. Schizophrenia Bulletin, 21(4):669-675, 1995.
77. Lewis, S.E., and Murray, R.M. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. Journal of Psychiatric Research, 21:413-421, 1987.
78. Lieberman, J.A.; Kinon, B.J.; and Loebel, A.D. Dopaminergic mechanisms in idiopathic and druginduced psychoses. Schizophrenia Bulletin, 16(1):97-110, 1990.
79. Lim, K.O.; Tew, W.; Kushner, M.; Chow, K.; Matsumoto, B.; and DeLisi, L.E. "Cortical Gray Matter Volume Deficit Is Present in First-Episode Schizophrenics." Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.
80. Lo, W.H., and Lo, T. A ten-year follow-up study of Chinese schizophrenics in Hong Kong. British Journal of Psychiatry, 131:63-66, 1977.
81. Loebel, A.D.; Lieberman, J.A.; Alvir, J.M.J.; Geisler, S.H.; Szymanski, S.R.; and Mayerhoff, D.I. "Consistency of Treatment Response Across Successive Psychotic Episodes in Recent-Onset Schizophrenia." Presented at the International Congress of Schizophrenia Research, Colorado Springs, CO, April 1993.
82. Loebel, A.D.; Lieberman, J.A.; Alvir, J.M.J.; Mayerhoff, D.I.; Geisler, S.H.; and Szymanski, S.R. Duration of psychosis and outcome in firstepisode schizophrenia. American Journal of Psychiatry, 149(9):1183-1188, 1992.
83. Mahendra, B. Where have all the catatonics gone? Psychological Medicine, 11:669-671, 1981.
84. McGlashan, T.H. Schizophrenia: Psychosocial therapies and the role of psychosocial factors in its etiology and pathogenesis. In: Frances, A.J., and Hales, R.E., eds. American Psychiatric Association Annual Review. Vol. V. Washington, DC: American Psychiatric Press, 1986. pp. 96-111.
85. McGlashan, T.H. A selective review of recent North American long-term followup studies of schizophrenia. Schizophrenia Bulletin, 14(4)515-542, 1988.
86. McGlashan, T.H., and Fenton, W.S. The positive-negative distinction in schizophrenia: Review of natural history validators. Archives of General Psychiatry, 49:63-72, 1992.
87. McGlashan, T.H., and Fenton, W.S. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin, 19(1):71-84, 1993.
88. McGorry, P.D. The concept of recovery and secondary prevention in psychotic disorders. Australian and New Zealand Journal of Psychiatry, 26:3-18, 1992.
89. McGorry, P.D.; Chanen, A.; McCarthy, E.; van Kiel, R.J.; Mckenzie, D.; and Singh, B.S. Posttraumatic stress disorder following recent-onset psychosis: An unrecognized postpsychotic syndrome. Journal of Nervous and Mental Disease, 179:253-258, 1991.
90. McGorry, P.D., and Kulkarni, J. Prevention and preventively oriented clinical care in psychotic disorders. Australian Journal of Psychopharmacology, 7:62-69, 1994.
91. Mehlum, L.; Friis, S.; Irion, T.; Johns, S.; Karterud, S.; Vaglum, P.; and Vaglum, S. Personality disorders 2-5 years after treatment: A prospective follow-up study. Acta Psychiatrica Scandinavica, 84:72-77, 1991.
92. Merriam, A.E.; Kay, S.R.; Opler, L.A.; Kushner, S.F.; and Van Praag, H.M. Neurological signs and the positive-negative dimension in schizophrenia. Biological Psychiatry, 28:181-192, 1990.
93. Mockler, D.M.; Sharma, T.; and Riordan, J.M. "Memory and Intellectual Decline in Schizophrenia." Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.
94. Moldin, S.O., and Erlenmeyer-Kimling, L. Measuring liability to schizophrenia: Progress report 1994: Editors' introduction. Schizophrenia Bulletin, 20(1):25-29, 1994.
95. Morrison, J.R. Changes in subtype diagnosis of schizophrenia: 1920-1966. American Journal of Psychiatry, 131:674-677, 1974.
96. Moscarelli, M. Health and economic evaluation in schizophrenia: Implications for health policies. Acta Psychiatrica Scandinavica, 89(Suppl. 382):84-88, 1984.
97. Moscarelli, M.; Capri, S.; and Neri, L. Cost evaluation of chronic schizophrenic patients during the first 3 years after the first contact. Schizophrenia Bulletin, 17(3):421-426, 1991.
98. Nasrallah, H.A. "Decreased Hippocampal Volume Over Time in Schizophrenia: Evidence of Neurodegeneration." Presented at the American Psychiatric Association Annual Meeting, Philadelphia, PA, May 1994.
99. National Institute of Mental Health. Special feature. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin, 21(4):839-843, 1985.
100. Nuechterlein, K.H.; Dawson, M.E.; Gitlin, M.; Ventura, J.; Goldstein, M.J.; Snyder, K.S.; Yee, C.M.; and Mintz, J. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18(3):387-425, 1992.
101. Ødegård, O. Changes in the prognosis of functional psychoses since the days of Kraepelin. British Journal of Psychiatry, 113:813-822, 1967.
102. O'Donnell, B.F.; Faux, S.F.; Mc-Carley, R.W.; Kimble, M.O.; Salisbury, D.F.; Nestor, P.G.; Kikinis, R.; Jolesz, F.A.; and Shenton, M.E. Increased rate of P300 latency prolongation with age in schizophrenia: Electrophysiological evidence for a neurodegenerative process. Archives of General Psychiatry, 52:544-549, 1995.
103. Opjordsmoen, S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatrica Scandinavica, 83:307-313, 1991.
104. Park, S.; Puschel, J.; Hauser, B.; and Hell, D. "Stability of Spatial Working Memory Deficit in Schizophrenia Patients." Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.
105. Pettegrew, J.W.; Keshavan, M.S.; and Minshew, N.J. Nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia. Schizophrenia Bulletin, 19(1):35-53, 1993.
106. Pfohl, B., and Winokur, G. The evolution of symptoms in institutionalized hebephrenic/ catatonic schizophrenics. British Journal of Psychiatry, 141:567-672, 1982.
107. Rabiner, C.J.; Wegner, J.T.; and Kane, J.M. Outcome study of first episode psychosis: I. Relapse rates after 1 year. American Journal of Psychiatry, 143(9):1155-1158, 1986.
108. Reitan, R.M., and Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press, 1985.
109. Romano, J. On the nature of schizophrenia: Changes in the observers as well as the observed (1932-77). Schizophrenia Bulletin, 3(4):532-559, 1977.
110. Rosvold, H.E.; Mirsky, A.; Sarasen, I.; Bransome, E.D., Jr.; and Beck, L.H. A continuous performance test of brain damage. Journal of Consulting Psychology, 20:343-350, 1956.
111. Sanson, A.; Oberklaid, F.; Pedlow, R.; and Prior, M. Risk indicators: Assessment of infancy predictors of pre-school behavioral maladjustment. Journal of Child Psychological Psychiatry, 32(4):609-626, 1991.
112. Sapolsky, R.M. Glucocorticoids, hippocampal damage and the glutamatergic synapse. Progress in Brain Research, 86:13-23, 1990.
113. Saykin, A.J.; Gur, R.C.; Gur, R.E.; Mozley, P.D.; Mozley, L.H.; Resnick, S.M.; Kester, D.B.; and Stafiniak, P. Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Archives of General Psychiatry, 48:618-624, 1991.
114. Saykin, A.J.; Shtasel, D.L.; Gur, R.E.; Kester, D.B.; Mozley, L.H.; Stafiniak, P.; and Gur, R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51:124-131, 1994.
115. Shtasel, D.L.; Gur, R.E.; Gallacher, F.; Heimberg, C.; Cannon, T.; and Gur, R.C. Phenomenology and functioning in first-episode schizophrenia. Schizophrenia Bulletin, 18(3):449-462, 1992.
116. Spitzer, R.L.; Endicott, J.; and Robins, E. Research Diagnostic Criteria: Rationale and reliability. Archives of General Psychiatry, 35:773-782, 1978a.
117. Spitzer, R.L.; Endicott, J.; and Robins, E. The Schedule for Affective Disorders and Schizophrenia-Change Version (SADS-C). New York, NY: Biometrics Research Unit, New York State Psychiatric Institute, 1978b.
118. Stoll, A.L.; Tohen, M.; Baldessarini, R.J.; Goodwin, D.C.; Stein, S.; Katz, S.; Geenens, D.; Swinson, R.P.; Goethe, J.W.; and McGlashan, T.H. Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. American Journal of Psychiatry, 150:1668-1673, 1993.
119. Stroop, J.R. Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18:643-662, 1935.
120. Sullivan, H.S. The onset of schizophrenia. [1927] American Journal of Psychiatry, 151(Suppl. 6):135-139, 1994.
121. Susser, E.S., and Shang, P. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Archives of General Psychiatry, 49:983-988, 1992.
122. Sweeney, J.A.; Haas, G.L.; and Li, S. Neuropsychological and eye movement abnormalities in firstepisode and chronic schizophrenia. Schizophrenia Bulletin, 18(2):283-293, 1992.
123. Tienari, P.; Sorri, A.; Lahti, I.; Naarala, M.; Wahlberg, K.E.; Ronkkot Pohjola, J.; and Moring, J. The Finnish Adoptive Family Study of Schizophrenia. Yale Journal of Biological Medicine, 58:227-237, 1985.
124. Waddington, J.L.; Youssef, H.A.; and Kinsella, A. Sequential cross-sectional and ten year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine, in press.
125. Wechsler, D. Manual for the Wechsler Adult Intelligence Scale. New York, NY: Psychological Corporation, 1955.
126. Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44:660-669, 1987.
127. Wing, J.; Cooper, J.; and Sartorius, N. The Description and Classification of Psychiatric Symptoms: An Instruction Manual for PSE and CATEGO System. London, England: Cambridge University Press, 1974.
128. Winokur, G.; Scharfetter, C.; and Angst, J. Stability of psychotic symptomatology (delusions, hallucinations), affective syndromes and schizophrenic symptoms (thought disorder, incongruent affect) over episodes in remitting psychoses. European Archives of Psychiatry and Neurological Science, 234:303-307, 1985.
129. Woods, B.T., and Yurgelun-Todd, D. Brain volume loss in schizophrenia: When does it occur and is it progressive? Schizophrenia Research, 5:202-203, 1991.
130. Wyatt, R.J. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17(2):325-351, 1991.
131. Wyatt, R.J. Risks of withdrawing antipsychotic medications. Archives of General Psychiatry, 52:205-208, 1995.
132. Youssef, H.A.; Kinsella, A.; and Waddington, J.L. "Extreme Negative Symptoms in Schizophrenia as a Correlate of Years of Untreated Psychosis Within a Rural Irish Population." Presented at the International Congress of Schizophrenia Research, Colorado Springs, CO, April 1993.
133. Youssef, H.A., and Waddington, J.L. "Cognitive Dysfunction in Schizophrenia Followed Prospectively Over 10 Years: Static Encephalopathy vs. Deterioration With Emergence of Tardive Dyskinesia." Presented at the International Congress on Schizophrenia Research, Warm Springs, VA, April 1995.